Since the highly-anticipated release of USP <800> there has been much discussion among healthcare pharmacies about the interpretation of these new guidelines---and what that will mean for their operations once implementation takes full effect later this year. During this workshop participants will examine the new standards and discover practical applications.

This workshop will offer CEs.

Key items addressed include:

• Facility design
• Creating an OSHA compliant HD List
• Shipping HDs
• OSHA Hazardous Communications Programs
• Respiratory protection
• Workflow considerations
• Personnel training
• Primary Engineering Controls (PECs)
• Deactivation and decontamination 

In addition, USP <797> has issued a revised draft.
We will cover key differences that are critical to your practice including:

• Changes to how BUDs (Beyond-Use Dates) may be assigned
• Testing requirements
• Revised facility requirements
• Gowning and garbing requirements

Learning Objectives:

• Define what is considered a hazardous drug
• Provide strategies to achieve USP <800> compliance
• Review proposed changes to USP <797>

Intended Audience:

This workshop is relevant to sterile and non-sterile compounders.